Development of a mathematical model that predicts the outcome of hormone therapy for prostate cancer
From MaRDI portal
Publication:1716254
DOI10.1016/j.jtbi.2010.02.027zbMath1406.92304OpenAlexW2046199531WikidataQ39898546 ScholiaQ39898546MaRDI QIDQ1716254
Nicholas Bruchovsky, Kazuyuki Aihara, Yoshito Hirata
Publication date: 4 February 2019
Published in: Journal of Theoretical Biology (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1016/j.jtbi.2010.02.027
Related Items (32)
Global analysis of the dynamics of a piecewise linear vector field model for prostate cancer treatment ⋮ Avoiding healthy cells extinction in a cancer model ⋮ A new protocol for intermittent androgen suppression therapy of prostate cancer with unstable saddle-point dynamics ⋮ Dynamics and implications of models for intermittent androgen suppression therapy ⋮ Predictability and identifiability assessment of models for prostate cancer under androgen suppression therapy ⋮ Estimating a non-homogeneous Gompertz process with jumps as model of tumor dynamics ⋮ Modeling the synergistic properties of drugs in hormonal treatment for prostate cancer ⋮ Optimal design of personalized prostate cancer therapy using infinitesimal perturbation analysis ⋮ Estimating and determining the effect of a therapy on tumor dynamics by means of a modified Gompertz diffusion process ⋮ Comparison between mathematical models of intermittent androgen suppression for prostate cancer ⋮ Optimization therapy by coupling intermittent androgen suppression with impulsive chemotherapy for a prostate cancer model ⋮ Selection of prostate cancer therapy strategy under early androgen suppression treatment ⋮ The dose-dense principle in chemotherapy ⋮ Analysis of mathematical model of prostate cancer with androgen deprivation therapy ⋮ Nonlinear system identification for prostate cancer and optimality of intermittent androgen suppression therapy ⋮ A time scales approach for modeling intermittent hormone therapy for prostate cancer ⋮ Parameter identification of a model for prostate cancer treated by intermittent therapy ⋮ A partial differential equation model and its reduction to an ordinary differential equation model for prostate tumor growth under intermittent hormone therapy ⋮ Achieving precise mechanical control in intrinsically noisy systems ⋮ A stochastic model of cancer growth subject to an intermittent treatment with combined effects: reduction in tumor size and rise in growth rate ⋮ Mathematical modeling of continuous and intermittent androgen suppression for the treatment of advanced prostate cancer ⋮ Global dynamics of a model of joint hormone treatment with dendritic cell vaccine for prostate cancer ⋮ Halting the hallmarks: a cellular automaton model of early cancer growth inhibition ⋮ Parameter estimation and optimal scheduling algorithm for a mathematical model of intermittent androgen suppression therapy for prostate cancer ⋮ A stochastic approach to risk management for prostate cancer patients on active surveillance ⋮ Ability of intermittent androgen suppression to selectively create a non-trivial periodic orbit for a type of prostate cancer patients ⋮ Intermittent hormone therapy models analysis and Bayesian model comparison for prostate cancer ⋮ Practically scheduling hormone therapy for prostate cancer using a mathematical model ⋮ The Impact of Fractional Differentiation in Terms of Fitting for a Prostate Cancer Model Under Intermittent Androgen Suppression Therapy ⋮ The parameter Houlihan: a solution to high-throughput identifiability indeterminacy for brutally ill-posed problems ⋮ Do mechanisms matter? Comparing cancer treatment strategies across mathematical models and outcome objectives ⋮ On tumoural growth and treatment under cellular dedifferentiation
Cites Work
- Differential evolution. A practical approach to global optimization. With CD-ROM.
- A nonlinear model with competition between prostate tumor cells and its application to intermittent androgen suppression therapy of prostate cancer
- Bifurcation analysis on a hybrid systems model of intermittent hormonal therapy for prostate cancer
- A mathematical model of prostate tumor growth and androgen-independent relapse
- Grey-box modelling and identification using physical knowledge and Bayesian techniques
- On selecting models for nonlinear time series
- For differential equations with \(r\) parameters, \(2r+1\) experiments are enough for identification
- Identification of nonlinear systems using empirical data and prior knowledge -- An optimization approach
- A mathematical model of intermittent androgen suppression for prostate cancer
- Incorporating prior knowledge in fuzzy model identification
- A COMPARATIVE STUDY OF INFORMATION CRITERIA FOR MODEL SELECTION
- MDL denoising
- Multiobjective nonlinear system identification: a case study with thyristor controlled series capacitor (TCSC)
This page was built for publication: Development of a mathematical model that predicts the outcome of hormone therapy for prostate cancer
